Interestingly, within the NSCLC cell lines, LKB1-wild type cells that show a clear decrease of MYC protein upon BAY 1238097 treatment also display a significantly higher sensitivity to the inhibitor than the cell lines in which MYC levels remain unchanged or slightly decreased (Figure 4A). The gene discussed is MYC; the disease is non-small cell lung carcinoma.